$LAZ

Lazard Stock Plunges 14% in 6 Months: Buy the Dip or Cut Your Losses?

Lazard Inc. (LAZ) stock has fallen 14.1% in six months, underperforming peers like Virtu Financial (VIRT) and Jefferies Financial (JEF). Weak earnings, high costs, and macroeconomic uncertainty weigh on its outlook. Analysts revised 2026 earnings down 10.6%, though 2027 estimates show an 83.6% increase. The company's valuation is high, with a P/B ratio of 5.3X. Management targets long-term growth but near-term challenges persist.

Original reporting
Published Aug 31, 2026, 5:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 1, 2026, 4:14 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Lazard Stock Plunges 14% in 6 Months: Buy the Dip or Cut Your Losses? — source image
Decision brief

The 30-second read

$LAZBearishMed
01

Why it matters

The miss reinforces a bearish outlook, supporting the current Strong Sell rating and suggesting further downside risk.

02

Market read

The earnings disappointment is likely to trigger short‑term selling pressure in LAZ and may influence sentiment toward similar advisory firms.

03

What to watch

Strong asset‑management growth and upcoming private‑market acquisition could offset advisory weakness.

Relevance 8/10Novelty 8/10Timing: Q2 2026 earnings release (after‑hours)

Background

Lazard Inc. reported a significant earnings miss for Q2 2026, with adjusted EPS of $0.12 versus $0.42 consensus, and highlighted ongoing liquidity constraints and a modest dividend yield.

Company-level read

Ticker impact

$LAZBearishHigh confidence
Context

Q2 2026 adjusted earnings of $0.12 per share missed the $0.42 consensus estimate, prompting a Zacks Rank #5 (Strong Sell).

Expected impact

potential short-term decline of 5‑10% as investors reassess earnings outlook.

Evidence & confidence

The miss is material and the consensus downgrade signals weaker near‑term profitability.

Market effects

Financial advisory segment pressure may weigh on peer advisory firms.

US investment banking and advisory services could see broader sentiment drag.

Limited; primarily affects US‑listed advisory and asset‑management stocks.

Counterpoint

If the company can turn around advisory revenue in H2, the stock may be oversold.

Key entities

  • Lazard Inc.

    Global financial advisory and asset‑management firm (ticker LAZ).

Related articles

$LAZMed

How Lazard’s (LAZ) Swiss Investment Banking Hire Will Impact DACH Advisory Ambitions

Lazard (LAZ) appointed Dr. Marco Superina as head of investment banking for Switzerland, focusing on M&A and capital solutions. The hire aims to strengthen Lazard's presence in the DACH region and engage with Swiss corporate and financial communities. Lazard projects $4.6 billion revenue and $573.6 million earnings by 2029, requiring 12.6% yearly revenue growth. The company recently increased its share repurchase authorization by $200 million, despite softer Q2 2026 earnings. Analysts have mixed

$LAZMed

Lazard, Inc. Q2 2026: Revenue $807.7M, EPS $0.03— 10-Q Summary

Lazard, Inc. (LAZ) reported Q2 2026 revenue of $807.7M, up 1% year over year, but profitability fell. Net income attributable to Lazard was $4.8M versus $55.3M a year earlier, and diluted EPS was $0.03 versus $0.52. Adjusted net revenue rose modestly as Asset Management gains offset weaker Financial Advisory fees. Lazard agreed to acquire Campbell Lutyens, with potential earnouts totaling about $660M+, expected to close in 2H 2026.

$LAZMed

Lazard Poaches From Goldman, AllianceBernstein for Asset Manager

Lazard Asset Management hired Chris Hogbin’s team, adding TP Enders from Goldman Sachs as head of product and Christopher Bricker from AllianceBernstein to lead corporate development. The moves follow Lazard reporting record client assets and $7.4 billion of first-half inflows, despite a $1.4 billion May withdrawal that cut Lazard shares about 13% on disclosure. Lazard oversees $285 billion.

$LAZMedAI 8/10

Lazard revamps advisory business, posts 91% drop in quarterly profit

Lazard reported a 91% year-over-year drop in second-quarter adjusted profit and said it cut more than 80 managing director roles as it restructures its financial advisory business. Quarterly revenue fell 9%. It plans to expand U.S. IPO advisory and expects ramp-up through 2027. Asset management revenue rose 23% to $331 million, with $285 billion AUM.